IPL therapy for MGD
Outcomes of a randomised controlled trialBy Dr Ally Xue, Dr Michael Wang, Dr Sue Ormonde and A/Prof Jennifer CraigEvaporative Dry Eye Evaporative disease is acknowledged to be the most prevalent dry
12 min read
PJ
Professor Jennifer Craig
19 articles
TFOS DEWS II: two years on…
In the two years since the Tear Film & Ocular Surface Society second Dry Eye Workshop (TFOS DEWS II) reports were published, most would agree that dry eye disease (DED) is closer to reaching household
5 min read
Dry eye: the New Zealand impact
It’s been full steam ahead for the Ocular Surface Laboratory (OSL) this year in the wake of TFOS DEWS II, ably assisted by Dr Alex Muntz, who joined the team in 2018. Research in the lab has continued
3 min read
So you want to set up a dry eye clinic?
It’s become clear, as our knowledge has evolved, that dry eye management, if performed thoroughly, cannot be squeezed into a normal examination as part of a standard eye examination. You wouldn’t expect to perform a full glaucoma work-up within a standard eye examination and neither should you expec
6 min read
Ocular Surface Laboratory update
Over the year there’s been a strong team of individuals working under the Ocular Surface Laboratory (OSL) banner. We look at some of what's been happening.
4 min read
TFOS DEWS II: a year on…
It’s been a full year since the outcomes of the Tear Film & Ocular Surface Society’s second Dry Eye Workshop (now better known as TFOS DEWS II) were released to the world in a series of 10 reports that distilled the scientific evidence and provided an updated global consensus view on various asp
7 min read
TFOS DEWS II and all that’s new with dry eye
Emerging from the buzz of TFOS DEWS II, I’m getting my first chance to step back and take stock of the work that 150 experts in the field have contributed, pro bono, to reach consensus on many aspects
5 min read